These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 30652071)

  • 1. Wild-type p53 regulates OTOP2 transcription through DNA loop alteration of the promoter in colorectal cancer.
    Qu H; Su Y; Yu L; Zhao H; Xin C
    FEBS Open Bio; 2019 Jan; 9(1):26-34. PubMed ID: 30652071
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The p53-inducible CLDN7 regulates colorectal tumorigenesis and has prognostic significance.
    Hou Y; Hou L; Liang Y; Zhang Q; Hong X; Wang Y; Huang X; Zhong T; Pang W; Xu C; Zhu L; Li L; Fang J; Meng X
    Neoplasia; 2020 Nov; 22(11):590-603. PubMed ID: 32992138
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Bcl-w promoter is activated by beta-catenin/TCF4 in human colorectal carcinoma cells.
    Lapham A; Adams JE; Paterson A; Lee M; Brimmell M; Packham G
    Gene; 2009 Mar; 432(1-2):112-7. PubMed ID: 19124064
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NF-κB-induced WIP1 expression promotes colorectal cancer cell proliferation through mTOR signaling.
    Bai F; Zhou H; Fu Z; Xie J; Hu Y; Nie S
    Biomed Pharmacother; 2018 Mar; 99():402-410. PubMed ID: 29367109
    [TBL] [Abstract][Full Text] [Related]  

  • 5. miR-300 promotes proliferation and EMT-mediated colorectal cancer migration and invasion by targeting p53.
    Wang L; Yu P
    Oncol Rep; 2016 Dec; 36(6):3225-3232. PubMed ID: 27779716
    [TBL] [Abstract][Full Text] [Related]  

  • 6. OTOP2, Inversely Modulated by miR-3148, Inhibits CRC Cell Migration, Proliferation and Epithelial-Mesenchymal Transition: Evidence from Bioinformatics Data Mining and Experimental Verification.
    Guo S; Sun Y
    Cancer Manag Res; 2022; 14():1371-1384. PubMed ID: 35418782
    [TBL] [Abstract][Full Text] [Related]  

  • 7. microRNA-1827 represses MDM2 to positively regulate tumor suppressor p53 and suppress tumorigenesis.
    Zhang C; Liu J; Tan C; Yue X; Zhao Y; Peng J; Wang X; Laddha SV; Chan CS; Zheng S; Hu W; Feng Z
    Oncotarget; 2016 Feb; 7(8):8783-96. PubMed ID: 26840028
    [TBL] [Abstract][Full Text] [Related]  

  • 8. UBTD1 induces cellular senescence through an UBTD1-Mdm2/p53 positive feedback loop.
    Zhang XW; Wang XF; Ni SJ; Qin W; Zhao LQ; Hua RX; Lu YW; Li J; Dimri GP; Guo WJ
    J Pathol; 2015 Mar; 235(4):656-67. PubMed ID: 25382750
    [TBL] [Abstract][Full Text] [Related]  

  • 9. AA-NAT, MT1 and MT2 Correlates with Cancer Stem-Like Cell Markers in Colorectal Cancer: Study of the Influence of Stage and p53 Status of Tumors.
    Casado J; Iñigo-Chaves A; Jiménez-Ruiz SM; Ríos-Arrabal S; Carazo-Gallego Á; González-Puga C; Núñez MI; Ruíz-Extremera Á; Salmerón J; León J
    Int J Mol Sci; 2017 Jun; 18(6):. PubMed ID: 28604612
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ING1 represses transcription by direct DNA binding and through effects on p53.
    Kataoka H; Bonnefin P; Vieyra D; Feng X; Hara Y; Miura Y; Joh T; Nakabayashi H; Vaziri H; Harris CC; Riabowol K
    Cancer Res; 2003 Sep; 63(18):5785-92. PubMed ID: 14522900
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cepharanthine exhibits a potent anticancer activity in p53-mutated colorectal cancer cells through upregulation of p21Waf1/Cip1.
    Rattanawong A; Payon V; Limpanasittikul W; Boonkrai C; Mutirangura A; Wonganan P
    Oncol Rep; 2018 Jan; 39(1):227-238. PubMed ID: 29138869
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutant p53 gain of function underlies high expression levels of colorectal cancer stem cells markers.
    Solomon H; Dinowitz N; Pateras IS; Cooks T; Shetzer Y; Molchadsky A; Charni M; Rabani S; Koifman G; Tarcic O; Porat Z; Kogan-Sakin I; Goldfinger N; Oren M; Harris CC; Gorgoulis VG; Rotter V
    Oncogene; 2018 Mar; 37(12):1669-1684. PubMed ID: 29343849
    [TBL] [Abstract][Full Text] [Related]  

  • 13. P-glycoprotein is not expressed in a majority of colorectal carcinomas and is not regulated by mutant p53 in vivo.
    De Angelis P; Stokke T; Smedshammer L; Lothe RA; Lehne G; Chen Y; Clausen OP
    Br J Cancer; 1995 Aug; 72(2):307-11. PubMed ID: 7640210
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PLAGL2 and POFUT1 are regulated by an evolutionarily conserved bidirectional promoter and are collaboratively involved in colorectal cancer by maintaining stemness.
    Li D; Lin C; Li N; Du Y; Yang C; Bai Y; Feng Z; Su C; Wu R; Song S; Yan P; Chen M; Jain A; Huang L; Zhang Y; Li X
    EBioMedicine; 2019 Jul; 45():124-138. PubMed ID: 31279780
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Paracrine Induction of Epithelial-Mesenchymal Transition Between Colorectal Cancer Cells and its Suppression by a p53/miR-192/215/NID1 Axis.
    Rokavec M; Bouznad N; Hermeking H
    Cell Mol Gastroenterol Hepatol; 2019; 7(4):783-802. PubMed ID: 30831320
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LKB1 loss at transcriptional level promotes tumor malignancy and poor patient outcomes in colorectal cancer.
    He TY; Tsai LH; Huang CC; Chou MC; Lee H
    Ann Surg Oncol; 2014 Dec; 21 Suppl 4():S703-10. PubMed ID: 24879590
    [TBL] [Abstract][Full Text] [Related]  

  • 17. p53 increase mitochondrial copy number via up-regulation of mitochondrial transcription factor A in colorectal cancer.
    Wen S; Gao J; Zhang L; Zhou H; Fang D; Feng S
    Oncotarget; 2016 Nov; 7(46):75981-75995. PubMed ID: 27732955
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA-552 links Wnt signaling to p53 tumor suppressor in colorectal cancer.
    Kwak B; Kim DU; Kim TO; Kim HS; Kim SW
    Int J Oncol; 2018 Oct; 53(4):1800-1808. PubMed ID: 30066856
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distinctive patterns of p53 protein expression and microsatellite instability in human colorectal cancer.
    Nyiraneza C; Jouret-Mourin A; Kartheuser A; Camby P; Plomteux O; Detry R; Dahan K; Sempoux C
    Hum Pathol; 2011 Dec; 42(12):1897-910. PubMed ID: 21665242
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ArhGAP30 promotes p53 acetylation and function in colorectal cancer.
    Wang J; Qian J; Hu Y; Kong X; Chen H; Shi Q; Jiang L; Wu C; Zou W; Chen Y; Xu J; Fang JY
    Nat Commun; 2014 Aug; 5():4735. PubMed ID: 25156493
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.